| Document Date: 2014-11-03 11:26:21
Open Document File Size: 14,86 KBShare Result on Facebook
City Osaka / / Company Influenza Shionogi & Co. Ltd. / Shionogi & Co. Ltd. / Corporate Communications Department Shionogi & Co. Ltd. / / Country Japan / / Event FDA Phase / / / IndustryTerm treatment of infectious diseases / foreign healthcare reforms / with respect to product / / MedicalCondition pediatric influenza infections / adult uncomplicated seasonal influenza infection / influenza infection / seasonal influenza virus infection / infectious diseases / infection / severe and life-threatening influenza / influenza A / influenza / / Person Isao Teshirogi / / / Position President / / Product Shionogi Files / RAPIACTA® / /
SocialTag |
February 15, 2010 Shionogi & Co., Ltd. Shionogi Files an Additional Application for Pediatric Use of “RAPIACTA®’’ a Novel Anti-viral Drug for Influenza